These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1223 related items for PubMed ID: 18365545

  • 1. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
    Geng X, Wang F, Li YG, Zhu GP, Zhang WM.
    J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
    [Abstract] [Full Text] [Related]

  • 2. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
    Wu C, Wang Z, Liu L, Zhao P, Wang W, Yao D, Shi B, Lu J, Liao P, Yang Y, Zhu L.
    J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
    O'Gorman D, Howard JC, Varallo VM, Cadieux P, Bowley E, McLean K, Pak BJ, Gan BS.
    Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
    [Abstract] [Full Text] [Related]

  • 10. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
    Zhang GQ, Du J, Pang D.
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach.
    Lee IN, Chen CH, Sheu JC, Lee HS, Huang GT, Chen DS, Yu CY, Wen CL, Lu FJ, Chow LP.
    Proteomics; 2006 May; 6(9):2865-73. PubMed ID: 16586433
    [Abstract] [Full Text] [Related]

  • 13. [Surface enhanced laser desorption/ionization time-of-flight mass spectrometry profiling of serum in detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis].
    Cheng L, Zhou L, Tao L, Zhang M, Cui JF, Liu YK.
    Zhonghua Yi Xue Za Zhi; 2007 Sep 25; 87(36):2526-30. PubMed ID: 18067823
    [Abstract] [Full Text] [Related]

  • 14. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.
    Zhou L, Cheng L, Tao L, Jia X, Lu Y, Liao P.
    Acta Otolaryngol; 2006 Aug 25; 126(8):853-60. PubMed ID: 16846929
    [Abstract] [Full Text] [Related]

  • 15. [Screening of differentially expressed proteins associated with directional highly lymphatic metastasis in ovarian carcinoma cell lines using SELDI-TOF-MS technology].
    Guan X, Li DR, Wang Q, Li L, Ruan HY, Zhang W.
    Ai Zheng; 2008 Nov 25; 27(11):1155-60. PubMed ID: 19000445
    [Abstract] [Full Text] [Related]

  • 16. Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.
    El-Aneed A, Banoub J.
    Anticancer Res; 2006 Nov 25; 26(5A):3293-300. PubMed ID: 17094443
    [Abstract] [Full Text] [Related]

  • 17. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
    Schipper R, Loof A, de Groot J, Harthoorn L, Dransfield E, van Heerde W.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb 15; 847(1):45-53. PubMed ID: 17070117
    [Abstract] [Full Text] [Related]

  • 18. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ, Huang G, Gao CF, Wang XL, Ma B, Sun LQ, Wei ZJ.
    Am J Clin Oncol; 2008 Apr 15; 31(2):133-9. PubMed ID: 18391596
    [Abstract] [Full Text] [Related]

  • 19. [Study of serum proteome biomarkers with relation to the formation of portal vein tumor thrombi in hepatocellular carcinoma patients].
    Huang C, Fan J, Zhou J, Liu YK, Cui JF, Kang XN, Yang PY, Tang ZY.
    Zhonghua Yi Xue Za Zhi; 2005 Mar 23; 85(11):781-5. PubMed ID: 15949388
    [Abstract] [Full Text] [Related]

  • 20. [The effects of different clinicopathologic variables on serum protein fingerprint in hepatocellular carcinoma patients].
    Huang C, Fan J, Zhou J, Liu YK, Cui JF.
    Zhonghua Wai Ke Za Zhi; 2006 Apr 01; 44(7):445-9. PubMed ID: 16772076
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.